COVID-19 in Alzheimer’s Disease and Dementia 1st Edition

COVID-19 in Alzheimer’s Disease and Dementia, 1st Edition by P. Hemachandra Reddy and Albin John delivers a timely, authoritative exploration of how the COVID-19 pandemic reshaped care, research, and outcomes for people living with Alzheimer’s disease and other dementias.

From the first paragraph you’ll be drawn into clear, evidence-rich explanations of viral interactions with the aging brain, neuroinflammation, and the mechanisms that may exacerbate cognitive decline after infection. The book balances rigorous science with practical insight—making complex topics accessible to clinicians, neurologists, researchers, public-health professionals, caregivers, and policy planners.

Readers will find in-depth analysis of clinical risk factors, diagnostic challenges, and the evolving picture of long COVID in dementia populations. The authors examine institutional vulnerabilities—from long-term care homes to community-based services—and offer regional perspectives relevant to North America, Europe, Asia, Africa, and Latin America, making the content globally and geographically relevant for international audiences.

Practical chapters guide safer care pathways, infection control strategies, telemedicine adaptation, and caregiver support approaches that reduce disruption while preserving dignity and quality of life. Case studies and up-to-date research syntheses underscore translational opportunities for therapeutics and rehabilitation.

Whether you seek to deepen scientific understanding, improve patient management, or inform public-health policy, this 1st Edition stands out as a comprehensive resource that bridges research and real-world application. Thoughtfully written and rigorously referenced, it is essential reading for anyone confronting the intersection of COVID-19 and neurodegenerative disease.

Order your copy today to equip your practice, research, or caregiving role with the latest clinical insights and actionable guidance.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.